Cyagen’s Post

I just have to share this invitation to our next webinar on incretins. If you are interested in metabolic disease, drug development and what imaging biomarkers can do for your metabolic drug development program - do join!

📢 Don't miss out on an upcoming webinar with Antaros Medical exploring the exciting future of incretin-based therapies in the treatment of diabetes and obesity! #Incretins have shown remarkable efficacy, but we're just scratching the surface of their potential. Join the experts as they delve into the intricacies of incretin biology, discuss the latest advancements, and explore innovative approaches to drug development in metabolic diseases and beyond. Discover how advanced imaging techniques like MRI and PET are revolutionizing our understanding of incretins and paving the way for novel treatment strategies. 💡 REGISTER HERE: https://buff.ly/3PEk5LN 🌟 Featured speakers: Tina Vilsbøll Michael Wagner Martin Schain #MetabolicDisease #Glucagon #WeightLossDrug #ClinicalTrialImaging #MuscleAssessment #Diabetes #DiabetesDrug #Type2Diabetes #Obesity

The Health Innovation Network has produced a summary detailing the success of its Lipid Management and Familial Hypercholesterolaemia (FH) national spread programme on improving cardiovascular health. The programme, which ran from October 2020 to March 2023, was successful in increasing the uptake of lipid lowering therapies, increasing the identification and management of people with FH, and enabling adoption of endorsed pathways. Over 9,000 CVD events, such as heart attacks or strokes, may have been prevented as a result, and many more people have been genetically confirmed with FH. Read the full report here: https://lnkd.in/eV9MmW3R Accelerated Access Collaborative #CardiovascularHealth #CVD #LipidManagement #FamilialHypercholesterolaemia

The integration of multimodal therapies is transforming cachexia management. During session H at the #SCWDConference2024 in Washington DC, experts Kam Kalantar-Zadeh, MD, MPH, PhD Mitja Lainscak Richard Skipworth presented the latest research on combining exercise, nutrition, and anti-inflammatory interventions in the treatment of cancer, heart failure, and renal cachexia. #Cachexia #Sarcopenia  #SCWD2024

Qarora.ai is world first AI-Integrated smart urinal designed to analyze 15+ urine biomarkers for the early detection of numerous kidney diseases known as silent killers such as diabetic nephropathy, chronic kidney diseases, kidney stones, renal tumours and urinary tract infections. By merging cutting-edge AI with non-invasive diagnostics, our technology provides real-time health insights through App and cloud platform to empower individuals, organizations, and communities.

Today on #WorldLiverDay, we acknowledge the vital role the liver plays in maintaining our health and well-being. As we focus on #LiverHealth, advancements in analytical technologies contribute significantly to our understanding and ability to diagnose liver-related conditions. At #Shimadzu, we're committed to advancing liver health research, and one of the tools utilised is Liquid Chromatograph Mass Spectrometry #LCMSMS. This cutting-edge technology allows us to precisely analyze #BileAcids, and crucial biomarkers for liver function assessment and disease diagnosis. 💡Explore how our 𝙇𝘾-𝙈𝙎/𝙈𝙎 𝙈𝙚𝙩𝙝𝙤𝙙 𝙋𝙖𝙘𝙠𝙖𝙜𝙚 𝙛𝙤𝙧 𝘽𝙞𝙡𝙚 𝘼𝙘𝙞𝙙𝙨 boosts liver health research and clinical diagnostics 🔗 https://lnkd.in/dJxM4nAG Together, let's continue to innovate and raise awareness about Liver Health to ensure healthier lives for all 🛡️

BME Seminar Series presents: Exploring new frontiers in disease research 🧬 The human extracellular matrix (ECM)— a vital structure supporting our tissues— plays a key role in maintaining health. When ECM regulation is disrupted, it’s linked to various diseases, including inflammatory bowel disease (IBD). Exciting new findings from Ana Maria Porras's lab reveal how the gut microbiome might directly influence ECM remodeling in the gut and even impact distant organs! She is pioneering in vitro methods to study this connection, hinting at a paradigm shift in our understanding of ECM and its impact on disease progression. #ASUEngineering #BiomedicalResearch #Microbiome #BMESeminarSeries #Innovation

Genetic tests can help identify individuals at risk of dying from prostate cancer, with lifestyle interventions such as reducing smoking and maintaining a healthy weight potentially preventing thousands of deaths. Factors like age, race, and genetic predisposition play a role in prostate cancer risk, highlighting the importance of personalized screenings and lifestyle modifications to reduce mortality rates. Integrating healthy habits like exercise and nutritious eating can contribute to lowering prostate cancer risk, particularly in high-risk individuals. #ProstateCancerPrevention #GeneticTesting #LifestyleInterventions #HealthandWellness #PreventiveHealth Read more here: https://lnkd.in/e-nMTVPi BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.

📢 Scientists Unlock Brown Fat Cells to Fight Obesity 📢 A German-Danish team has discovered a way to transform fat-storing white adipocytes into fat-burning brown adipocytes. 🔥 This breakthrough could revolutionize obesity research and lead to long-term effects in obese patients. 🐭 The researchers found that blocking a specific enzyme fragment called AC3-AT in brown fat cells helped mice combat obesity and increase their metabolic rates. 💡 The team believes this finding could pave the way for therapies that activate brown fat and tackle obesity in humans. 👩🔬 Further research is needed to understand the therapeutic impact of this discovery and other regulatory mechanisms in brown fat cells. #BioprocessUpdates #ObesityResearch #BrownFatCells #FatBurning #MetabolicRates #ObesityTreatments #Therapies #ResearchBreakthrough #AC3AT #WhiteAdipocytes #ObesePatients #GermanDanishTeam #RegulatoryMechanisms #LongTermEffects #TherapeuticImpact #ActivatingBrownFat ▷ Read the full article here: 📎 https://lnkd.in/dzj2THQX

The Health Innovation Network has produced a summary detailing the success of its #LipidManagement and #FamilialHypercholesterolaemia national spread programme on improving cardiovascular health. The programme, which ran from October 2020 to March 2023, was successful in increasing the uptake of lipid lowering therapies, increasing the identification and management of people with FH, and enabling adoption of endorsed pathways. Over 9,000 CVD events, such as heart attacks or strokes, may have been prevented as a result, and many more people have been genetically confirmed with familial hypercholesterolaemia. Read the full report here: https://lnkd.in/eV9MmW3R Accelerated Access Collaborative #cardiovascularhealth #CVD Find out more what we're doing locally in Wessex: https://lnkd.in/eRY3NjSr